Follow the people · Insider
Weiguo Ye
Weiguo Ye files insider transactions with the SEC as a chief operating officer of Gyre Therapeutics (GYRE). We hold 16 disclosed purchases and sales filed since 22 November 2023, 6 of them in the last 90 days.
- Files forGYRE
- Disclosed buys and sells16 in all, 6 in the last 90 days
- Last disclosure22 June 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 November 2023 — 18 June 2026Chief Operating Officer · Gyre Therapeutics (GYRE)58 Form 4 lines · source: SEC Form 4
Everything they disclosed
58 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 3,000 shares of Gyre TherapeuticsSEC Form 422 June 2026Common Stock · traded 9 June 2026 · filed 22 June 2026
- ▼ sold on the open market 3,000 shares of Gyre TherapeuticsSEC Form 422 June 2026Common Stock · traded 9 June 2026 · filed 22 June 2026
- exercised options over 5,000 shares of Gyre TherapeuticsSEC Form 422 June 2026Common Stock · traded 10 June 2026 · filed 22 June 2026
- ▼ sold on the open market 5,000 shares of Gyre TherapeuticsSEC Form 422 June 2026Common Stock · traded 10 June 2026 · filed 22 June 2026
- exercised options over 3,000 shares of Gyre TherapeuticsSEC Form 422 June 2026Common Stock · traded 18 June 2026 · filed 22 June 2026
- ▼ sold on the open market 3,000 shares of Gyre TherapeuticsSEC Form 422 June 2026Common Stock · traded 18 June 2026 · filed 22 June 2026
- exercised options over 3,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 422 June 2026Stock Option (Right to Buy) · traded 9 June 2026 · filed 22 June 2026
- exercised options over 5,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 422 June 2026Stock Option (Right to Buy) · traded 10 June 2026 · filed 22 June 2026
- exercised options over 3,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 422 June 2026Stock Option (Right to Buy) · traded 18 June 2026 · filed 22 June 2026
- exercised options over 2,800 shares of Gyre TherapeuticsSEC Form 415 June 2026Common Stock · traded 11 June 2026 · filed 15 June 2026
- ▼ sold on the open market 2,800 shares of Gyre TherapeuticsSEC Form 415 June 2026Common Stock · traded 11 June 2026 · filed 15 June 2026
- exercised options over 2,800 shares of Gyre Therapeutics (a derivative holding)SEC Form 415 June 2026Stock Option (Right to Buy) · traded 11 June 2026 · filed 15 June 2026
- exercised options over 14,500 shares of Gyre TherapeuticsSEC Form 411 June 2026Common Stock · traded 9 June 2026 · filed 11 June 2026
- ▼ sold on the open market 14,500 shares of Gyre TherapeuticsSEC Form 411 June 2026Common Stock · traded 9 June 2026 · filed 11 June 2026
- exercised options over 6,418 shares of Gyre TherapeuticsSEC Form 411 June 2026Common Stock · traded 10 June 2026 · filed 11 June 2026
- ▼ sold on the open market 6,418 shares of Gyre TherapeuticsSEC Form 411 June 2026Common Stock · traded 10 June 2026 · filed 11 June 2026
- exercised options over 14,500 shares of Gyre Therapeutics (a derivative holding)SEC Form 411 June 2026Stock Option (Right to Buy) · traded 9 June 2026 · filed 11 June 2026
- exercised options over 6,418 shares of Gyre Therapeutics (a derivative holding)SEC Form 411 June 2026Stock Option (Right to Buy) · traded 10 June 2026 · filed 11 June 2026
- exercised options over 19,575 shares of Gyre TherapeuticsSEC Form 48 June 2026Common Stock · traded 4 June 2026 · filed 8 June 2026
- ▼ sold on the open market 19,575 shares of Gyre TherapeuticsSEC Form 48 June 2026Common Stock · traded 4 June 2026 · filed 8 June 2026
- exercised options over 15,401 shares of Gyre TherapeuticsSEC Form 48 June 2026Common Stock · traded 5 June 2026 · filed 8 June 2026
- ▼ sold on the open market 15,401 shares of Gyre TherapeuticsSEC Form 48 June 2026Common Stock · traded 5 June 2026 · filed 8 June 2026
- exercised options over 19,575 shares of Gyre Therapeutics (a derivative holding)SEC Form 48 June 2026Stock Option (Right to Buy) · traded 4 June 2026 · filed 8 June 2026
- exercised options over 15,401 shares of Gyre Therapeutics (a derivative holding)SEC Form 48 June 2026Stock Option (Right to Buy) · traded 5 June 2026 · filed 8 June 2026
- exercised options over 3,500 shares of Gyre TherapeuticsSEC Form 427 May 2026Common Stock · traded 22 May 2026 · filed 27 May 2026
- ▼ sold on the open market 3,500 shares of Gyre TherapeuticsSEC Form 427 May 2026Common Stock · traded 22 May 2026 · filed 27 May 2026
- exercised options over 4,000 shares of Gyre TherapeuticsSEC Form 427 May 2026Common Stock · traded 26 May 2026 · filed 27 May 2026
- ▼ sold on the open market 4,000 shares of Gyre TherapeuticsSEC Form 427 May 2026Common Stock · traded 26 May 2026 · filed 27 May 2026
- exercised options over 3,500 shares of Gyre Therapeutics (a derivative holding)SEC Form 427 May 2026Stock Option (Right to Buy) · traded 22 May 2026 · filed 27 May 2026
- exercised options over 4,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 427 May 2026Stock Option (Right to Buy) · traded 26 May 2026 · filed 27 May 2026
- exercised options over 9,400 shares of Gyre TherapeuticsSEC Form 422 May 2026Common Stock · traded 20 May 2026 · filed 22 May 2026
- ▼ sold on the open market 9,400 shares of Gyre TherapeuticsSEC Form 422 May 2026Common Stock · traded 20 May 2026 · filed 22 May 2026
- exercised options over 12,820 shares of Gyre TherapeuticsSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- ▼ sold on the open market 12,820 shares of Gyre TherapeuticsSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- exercised options over 9,400 shares of Gyre Therapeutics (a derivative holding)SEC Form 422 May 2026Stock Option (Right to Buy) · traded 20 May 2026 · filed 22 May 2026
- exercised options over 12,820 shares of Gyre Therapeutics (a derivative holding)SEC Form 422 May 2026Stock Option (Right to Buy) · traded 21 May 2026 · filed 22 May 2026
- exercised options over 200 shares of Gyre TherapeuticsSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- ▼ sold on the open market 200 shares of Gyre TherapeuticsSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- exercised options over 9,120 shares of Gyre TherapeuticsSEC Form 420 May 2026Common Stock · traded 19 May 2026 · filed 20 May 2026
- ▼ sold on the open market 9,120 shares of Gyre TherapeuticsSEC Form 420 May 2026Common Stock · traded 19 May 2026 · filed 20 May 2026
- exercised options over 200 shares of Gyre Therapeutics (a derivative holding)SEC Form 420 May 2026Stock Option (Right to Buy) · traded 18 May 2026 · filed 20 May 2026
- exercised options over 9,120 shares of Gyre Therapeutics (a derivative holding)SEC Form 420 May 2026Stock Option (Right to Buy) · traded 19 May 2026 · filed 20 May 2026
- exercised options over 15,580 shares of Gyre TherapeuticsSEC Form 418 May 2026Common Stock · traded 14 May 2026 · filed 18 May 2026
- ▼ sold on the open market 15,580 shares of Gyre TherapeuticsSEC Form 418 May 2026Common Stock · traded 14 May 2026 · filed 18 May 2026
- exercised options over 13,100 shares of Gyre TherapeuticsSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 13,100 shares of Gyre TherapeuticsSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- exercised options over 15,580 shares of Gyre Therapeutics (a derivative holding)SEC Form 418 May 2026Stock Option (Right to Buy) · traded 14 May 2026 · filed 18 May 2026
- exercised options over 13,100 shares of Gyre Therapeutics (a derivative holding)SEC Form 418 May 2026Stock Option (Right to Buy) · traded 15 May 2026 · filed 18 May 2026
- exercised options over 50,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 414 May 2025Stock Option (Right to Buy) · traded 1 April 2025 · filed 14 May 2025
- exercised options over 50,000 shares of Gyre TherapeuticsSEC Form 414 May 2025Common Stock · traded 1 April 2025 · filed 14 May 2025
- exercised options over 300,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 425 April 2025Stock Option (Right to Buy) · traded 24 March 2025 · filed 25 April 2025
- exercised options over 200,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 425 April 2025Stock Option (Right to Buy) · traded 26 March 2025 · filed 25 April 2025
- exercised options over 150,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 425 April 2025Stock Option (Right to Buy) · traded 27 March 2025 · filed 25 April 2025
- exercised options over 300,000 shares of Gyre TherapeuticsSEC Form 425 April 2025Common Stock · traded 24 March 2025 · filed 25 April 2025
- exercised options over 200,000 shares of Gyre TherapeuticsSEC Form 425 April 2025Common Stock · traded 26 March 2025 · filed 25 April 2025
- exercised options over 150,000 shares of Gyre TherapeuticsSEC Form 425 April 2025Common Stock · traded 27 March 2025 · filed 25 April 2025
- was granted 300,000 shares of Gyre Therapeutics (a derivative holding)SEC Form 411 March 2025Stock Option (Right to Buy) · traded 7 March 2025 · filed 11 March 2025
- was granted 1,665,115 shares of Gyre Therapeutics (a derivative holding)SEC Form 422 November 2023Stock Option (Right to Buy) · traded 20 November 2023 · filed 22 November 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.